Gov. Ned Lamont and Health Commissioner Manisha Juthani have urged adult residents to get inoculated ahead of the holidays.
Johnson & Johnson
Posted inHealth
Connecticut to receive $300 million from settlement with opioid distributors
The deal is part of a larger, $26 billion settlement the companies negotiated with state and local governments.
Posted inHealth
More COVID vaccines are being wasted as demand drops
Nearly a third of all wasted COVID vaccine doses in CT were lost since the end of May.
Posted inHealth
Clinics across Connecticut to start taking walk-ups for COVID vaccine
Dozens of clinics will begin taking walk-ups on Tuesday
Posted inPolitics
Lamont faults CDC on J&J vaccine pause: ‘I would have handled it differently’
Gov. Ned Lamont and other governors expressed dismay to the White House over pausing the Johnson & Johnson vaccine.
Posted inHealth
The J&J vaccine: What we know, what we don’t know, and where we go from here
Officials ‘paused’ administration of the vaccine on Tuesday
Posted inHealth
Lamont: With thousands fewer J&J COVID vaccine doses, CT will have to make do for a time
Manufacturing problems will delay thousands of Johnson & Johnson COVID-19 vaccines from reaching Connecticut in the coming weeks.
Posted inHealth
The vaccine effect: COVID cases jump, not hospitalizations or fatalities
Officials credit Connecticut’s success in vaccinating older residents for keeping the COVID-19 death rate low as cases rise.
Posted inPolitics
Connecticut sends COVID-19 distribution plan to CDC
The proposal calls for a three-stage distribution plan, but complex logistics remain unresolved.
Posted inHealth
COVID-19 vaccine makers seek diversity in clinical trials in Connecticut and elsewhere
While Blacks and Latinos are hardest hit by the coronavirus, they are wary of participating in vaccine trials.
Posted inJustice
Rejecting Purdue settlement, CT hopes to gain from other opioid deals
Dozens of drug companies, and others blamed for the opioid crisis may follow Purdue Pharma’s lead and try to settle claims against them.
Posted inHealth, Justice
Growing number of states press opioid suits against Stamford’s Purdue Pharma
Updated at 10:15 a.m. with industry comment
WASHINGTON — Stamford-based Purdue Pharma, the maker of pain-killer OxyContin, is the target of an increasing number of suits by states, counties and cities alleging it is partly to blame for the nation’s opioid epidemic. The lawsuits are all different and some include other pharmaceutical companies and pharmacies as defendants. But Purdue is nearly always a main defendant.